Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
Background and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2016-08-01
|
Series: | Endoscopy International Open |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609 |
id |
doaj-d2aaa0195a4b409694bd5a01a106de3a |
---|---|
record_format |
Article |
spelling |
doaj-d2aaa0195a4b409694bd5a01a106de3a2020-11-25T03:41:45ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362016-08-010408E841E84810.1055/s-0042-109609Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy aloneShinya Kondo0Masahiro Tajika1Tsutomu Tanaka2Takeshi Kodaira3Nobumasa Mizuno4Kazuo Hara5Susumu Hijioka6Hiroshi Imaoka7Hidemi Goto8Kenji Yamao9Yasumasa Niwa10Department of Gastroenterology, Aichi Cancer Center Aichi Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanBackground and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the effectiveness and prognostic factors of salvage endoscopic resection were investigated. Patients and methods: A total of 37 patients with esophageal squamous cell carcinoma (SCC) who underwent salvage endoscopic resection after definitive chemoradiotherapy or radiotherapy alone were reviewed. The method of salvage endoscopic resection was endoscopic mucosal resection using a cap (EMR-C), strip biopsy, or endoscopic submucosal dissection. The effectiveness and prognostic factors of salvage endoscopic resection were retrospectively analyzed. Results: A total of 37 patients with 49 lesions underwent salvage endoscopic resection. Baseline clinical stages were I in 23 patients, II in 3 patients, III in 9 patients, and IV in 2 patients. The number of locoregional recurrences and residual lesions were 35 and 14, respectively. The curative en bloc resection rate was 53.1 % (26/49). The total incidence of complications was 18.9 % (7/37); all were successfully managed conservatively. The 3-year and 5-year overall survival rates were 72.9 % and 53.3 %, respectively, with a median follow-up period of 54 months. Baseline clinical T1 – 2 and N0 were significant factors for good prognosis in terms of overall survival on univariate analysis. Conclusions: Salvage endoscopic resection, especially EMR-C, is a safe and feasible procedure to control residual or recurrent superficial esophageal SCC after definitive chemoradiotherapy or radiotherapy alone. The present results showed that baseline clinical T1 – 2 and N0 before chemoradiotherapy or radiotherapy were significant prognostic factors.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shinya Kondo Masahiro Tajika Tsutomu Tanaka Takeshi Kodaira Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Hidemi Goto Kenji Yamao Yasumasa Niwa |
spellingShingle |
Shinya Kondo Masahiro Tajika Tsutomu Tanaka Takeshi Kodaira Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Hidemi Goto Kenji Yamao Yasumasa Niwa Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone Endoscopy International Open |
author_facet |
Shinya Kondo Masahiro Tajika Tsutomu Tanaka Takeshi Kodaira Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Hidemi Goto Kenji Yamao Yasumasa Niwa |
author_sort |
Shinya Kondo |
title |
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
title_short |
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
title_full |
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
title_fullStr |
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
title_full_unstemmed |
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
title_sort |
prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone |
publisher |
Georg Thieme Verlag KG |
series |
Endoscopy International Open |
issn |
2364-3722 2196-9736 |
publishDate |
2016-08-01 |
description |
Background and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the effectiveness and prognostic factors of salvage endoscopic resection were investigated.
Patients and methods: A total of 37 patients with esophageal squamous cell carcinoma (SCC) who underwent salvage endoscopic resection after definitive chemoradiotherapy or radiotherapy alone were reviewed. The method of salvage endoscopic resection was endoscopic mucosal resection using a cap (EMR-C), strip biopsy, or endoscopic submucosal dissection. The effectiveness and prognostic factors of salvage endoscopic resection were retrospectively analyzed.
Results: A total of 37 patients with 49 lesions underwent salvage endoscopic resection. Baseline clinical stages were I in 23 patients, II in 3 patients, III in 9 patients, and IV in 2 patients. The number of locoregional recurrences and residual lesions were 35 and 14, respectively. The curative en bloc resection rate was 53.1 % (26/49). The total incidence of complications was 18.9 % (7/37); all were successfully managed conservatively. The 3-year and 5-year overall survival rates were 72.9 % and 53.3 %, respectively, with a median follow-up period of 54 months. Baseline clinical T1 – 2 and N0 were significant factors for good prognosis in terms of overall survival on univariate analysis.
Conclusions: Salvage endoscopic resection, especially EMR-C, is a safe and feasible procedure to control residual or recurrent superficial esophageal SCC after definitive chemoradiotherapy or radiotherapy alone. The present results showed that baseline clinical T1 – 2 and N0 before chemoradiotherapy or radiotherapy were significant prognostic factors. |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609 |
work_keys_str_mv |
AT shinyakondo prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT masahirotajika prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT tsutomutanaka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT takeshikodaira prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT nobumasamizuno prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT kazuohara prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT susumuhijioka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT hiroshiimaoka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT hidemigoto prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT kenjiyamao prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone AT yasumasaniwa prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone |
_version_ |
1724528583866580992 |